First thalidomide clinical trial in multiple myeloma: a decade

The clinical outcomes of 169 patients enrolled in the first clinical trial of thalidomide for advanced or refractory myeloma are updated. Seventeen patients remain alive and 10 are event-free, with a median follow-up of 9.2 years. According to multivariate analysis of pretreatment variables, cytogen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: van Rhee, Frits, Dhodapkar, Madhav, Shaughnessy, John D., Anaissie, Elias, Siegel, David, Hoering, Antje, Zeldis, Jerome, Jenkins, Bonnie, Singhal, Seema, Mehta, Jayesh, Crowley, John, Jagannath, Sundar, Barlogie, Bart
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2008
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515147/
https://ncbi.nlm.nih.gov/pubmed/18502827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-02-140954
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge